Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.24.1
STOCKHOLDERS' EQUITY (Details)
 12 Months Ended
Sep. 08, 2023
USD ($)
$ / shares
shares
Oct. 25, 2022
USD ($)
$ / shares
shares
Oct. 20, 2022
USD ($)
Jun. 27, 2022
Jun. 24, 2022
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Oct. 25, 2023
shares
Oct. 24, 2023
shares
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares | shares           28,002,379      
Proceeds from exercise of warrants | $           $ 789,642      
Number of warrants exercised | shares           177,877 0    
Reverse stock split       0.10          
Common stock, shares authorized | shares           170,000,000 170,000,000 170,000,000 160,000,000
Aggregate value of shares issued | $           $ 17,920,000      
Common stock par value | $ / shares           $ 0.00001 $ 0.00001    
September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Gross proceeds | $ $ 24,500,000                
Net proceeds | $ $ 22,200,000                
Common Stock                  
STOCKHOLDERS' EQUITY                  
Conversion of pre-funded warrants into common shares (in shares) | shares           9,947,684      
Minimum | Common Stock                  
STOCKHOLDERS' EQUITY                  
Reverse stock split         0.10        
Maximum | Common Stock                  
STOCKHOLDERS' EQUITY                  
Reverse stock split         0.20        
Preferred Stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Number of shares converted | shares 905.24                
Common Stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Convertible preferred shares issued | shares 9,947,684                
Series E Warrants | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Share price | $ / shares $ 20,000                
Series E-1 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Shares issued | shares 1,225                
Conversion price per share | $ / shares $ 1.82                
Convertible preferred shares issued | shares 13,461,538                
Gross proceeds from stockholders' equity | $ $ 17,920,000                
Series E-2 Preferred Stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Common stock par value | $ / shares $ 1.82                
Series E-3 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Conversion price per share | $ / shares $ 3.185                
Convertible preferred shares issued | shares 13,846,154                
Series E-4 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Conversion price per share | $ / shares $ 4.7775                
Convertible preferred shares issued | shares 7,179,487                
Tranche A and B Warrants | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Gross proceeds from stockholders' equity | $ $ 4,700,000                
October 2022 Public Offering and Private Placement                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares | shares   3,275,153              
Gross proceeds | $   $ 10,700,000              
Proceeds from exercise of warrants | $           $ 348,638      
Exercise price of warrants (in dollars per share) | $ / shares   $ 2.085              
Class of warrant or rights from which warrants or rights exercisable. | $ / shares   $ 0.00001              
Estimated offering expenses | $   $ 9,600,000              
Gross proceeds from stockholders' equity | $     $ 10,700,000            
October 2022 Public Offering and Private Placement | Common Stock                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares | shares   1,875,945              
Exercise price of warrants (in dollars per share) | $ / shares   $ 1.96              
Common Stock | October 2022 Public Offering and Private Placement                  
STOCKHOLDERS' EQUITY                  
Gross proceeds from stockholders' equity | $     4,000,000.0            
Common warrants | October 2022 Public Offering and Private Placement                  
STOCKHOLDERS' EQUITY                  
Conversion of pre-funded warrants into common shares (in shares) | shares           355,235      
Gross proceeds from stockholders' equity | $     4,400,000            
Prefunded Warrant | October 2022 Public Offering and Private Placement                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares | shares   1,875,945              
Exercise price of warrants (in dollars per share) | $ / shares   $ 2.08499              
pre-funded warrants | shares           355,235      
Gross proceeds from stockholders' equity | $     $ 2,300,000            
2023 Tranche A Preferred Warrants | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Proceeds from exercise of warrants | $ $ 44,100,000                
2023 Tranche A Preferred Warrants | Series E-3 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares | shares 2,205                
Number of days | $ 10                
2023 Tranche B Preferred Warrants | Series E-4 preferred stock | September 2023 Private Placement                  
STOCKHOLDERS' EQUITY                  
Warrants issued to purchase shares | shares 1,715                
Proceeds from exercise of warrants | $ $ 34,300,000                
Number of days | $ 10